AzTrials
AzTrials

AnesthesiaNCT05427292

Combination of Serratus Anterior and Pectoral Nerve Blocks (PECS II) as Main Anesthetic Method in Breast Cancer Surgery

An observational study of Anesthesia, run by Samsun University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim of this study is to determine the success of combined serratus anterior and PECS-2 block as the main anesthetic method in breast cancer surgery and also to investigate the patient acceptability of this combination and its relationship with surgeon satisfaction. Read more about this study

Who is it for?
Ages 18 to 80 years, women only
Conditions the study is for
Anesthesia
What is being tested?
serratus anterior block and PECs II block combination
How many people
17 participants
Where
2 sitesTurkey (Türkiye)
Study dates
7 Jul 2022to 7 Jul 2023
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Female patients aged 18-80 years with breast cancer

Who may be able to join

  • Patients between the ages of 18-80 and ASA I-III who will undergo unilateral breast cancer surgery will be included in the study.

Who cannot join

  • Patients with previous breast surgery other than excisional biopsy,
  • coagulopathy,
  • bleeding disease,
  • local infection at the injection site,
  • history of local anesthetic allergy,
  • psychiatric disease (depression, mania, schizophrenia or antipsychotic drug use),
Show all 9Show fewer
  • history of opioid use for more than 4 weeks
  • Patients with body mass index (BMI) >40kg/m2 and
  • chest deformity (pectus excavatum and pectus carinatum) will be excluded from the study.

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Samsun University

    Samsun, Ilkadım, 55100

  • Samsun University

    Samsun, 55040

Other trials in Turkey (Türkiye)

About this study

Official title: Feasibilty of Serratus Anterior and Pectoral Nerve Blocks (PECS II) Combination as Main Anesthetic Method in Breast Cancer Surgery Patients

Aim of this study is to determine the success of combined serratus anterior and PECS-2 block as the main anesthetic method in breast cancer surgery and also to investigate the patient acceptability of this combination and its relationship with surgeon satisfaction.

Read the detailed description

Breast conserving surgery or mastectomy is applied in the surgical treatment of breast cancer. Axillary interventions range from sentinal lymph node biopsy to lymph node dissection. Clinically significant acute pain develops following breast surgery in 35% of patients.

Today, regional anesthesia is widely used as an opioid-sparing strategy in the treatment of acute postoperative pain. New fascial plane blocks have been developed as alternative or complementary techniques for chest wall analgesia, including pectoral nerve blocks (PECS1-2) and serratus plane block.

In order to reduce the risk of perioperative morbidity and mortality and to meet the patient demand, the demand for awake surgery is increasing in institutions.

Therefore, a prospective observational case series was conducted to explain the efficacy, patient acceptability, and surgeon satisfaction of combined serratus anterior and PECS-2 block as the main anesthetic method for breast cancer surgery.

Conditions
Anesthesia
Being tested
serratus anterior block and PECs II block combination
Keywords
regional anesthesia, interfascial plane block, Main anesthetic method

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • serratus anterior block and PECs II block combinationOther

    The pre-surgery block will be applied. Sensorial block will be evaluated at the surgical incision site with the pinpirick test at 30 minutes after the block, and if the block is successful, surgery will begin.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sufficient surgical anesthesia

    After confirming the sensory block in the surgical area with the post-procedure pinpirick test, successful completion of the surgical procedure 'without the need for deep sedoanalgesia' will be considered 'sufficient surgical anesthesia'.

    Measured: up to 30 minutes

Secondary outcomes (6)
  1. Pain scores on the Numeric Rating Scale (NRS)

    Changes in Numeric Rating Scale (NRS) at rest and on movement will be recorded at intervals. NRS is a unidimensional measure of pain intensity in adults. The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    Measured: up to 24 hours

  2. Quality of recovery 15 scale

    Postoperative Quality of Recovery 15 in Turkish scale

    Measured: up to 24 hours

  3. analgesic consumption

    In the postoperative period, patients will be given opioids according to their pain density with a patient-controlled device, and the daily Morphine consumption in Patient Controlled Analgesia device will be collected

    Measured: up to 24 hours

  4. modified Wilson Sedation Scale

    1. Oriente, eyes may be closed, but says his name, answers where he is
    2. Sleepy, eyes may be closed, can be warned when called by name
    3. Can be stimulated by mild physical stimulation (earlobe)
    4. Cannot be stimulated by mild physical stimulation

    Measured: up to 2 hours

  5. quality of anesthesia

    Are you satisfied with the anesthesia? Would you like to have surgery with the same technique again? Would you recommend it to others?

    1. Extremely satisfied,
    2. Satisfied,
    3. Neither satisfied nor dissatisfied,
    4. Not satisfied,
    5. It will be calculated by responding as highly dissatisfied.

    Measured: up to 2 hours

  6. scaling working conditions

    Working conditions scaling

    Indistinguishable from general anesthesia A little challenging/enough It will be determined by choosing one of the overly challenging/inadequate options.

    Measured: up to 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2022
  2. Study start7 Jul 2022
  3. Primary completion7 Jul 2023
  4. Study completion7 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
17 participants (actual)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT05427292
Sponsor's protocol ID
SamsunU
Status last verified
Jul 2023
First submitted
13 Jun 2022
Last updated
10 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Pawa A, Wight J, Onwochei DN, Vargulescu R, Reed I, Chrisman L, Pushpanathan E, Kothari A, El-Boghdadly K. Combined thoracic paravertebral and pectoral nerve blocks for breast surgery under sedation: a prospective observational case series. Anaesthesia. 2018 Apr;73(4):438-443. doi: 10.1111/anae.14213. Epub 2018 Jan 12.

    PubMed 29327341
  • Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012 Nov;59(9):470-5. doi: 10.1016/j.redar.2012.07.003. Epub 2012 Aug 29.

    PubMed 22939099

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia, run by Samsun University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sufficient surgical anesthesia (time frame: up to 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05427292, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in